Compare FirstEnergy Corp. (FE) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FirstEnergy Corp. vs TransMedics Group Inc — how do they compare? FirstEnergy Corp. trades at $46.78 (market cap $27.10B), while TransMedics Group Inc trades at $86.41 (market cap $3.10B). The key difference: FirstEnergy Corp. is far larger — about 8.7× TransMedics Group Inc's market cap, and FirstEnergy Corp. pays a 3.97% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| FE | TMDX | |
|---|---|---|
Market Cap | $27.10B | $3.10B |
Sector | Utilities | Technology |
52-Week High | $51.91 | $150.42 |
52-Week Low | $42.83 | $61.99 |
Enterprise Value | $56.02B | $3.49B |
Dividend Yield | 3.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FirstEnergy (FE) trades at $46.76, down 1.5% with bearish technical signals despite recent earnings beat. The utility shows steady revenue growth to $15.09B (2025) and maintains a 6.86% net margin, though EPS performance has been mixed. Analyst consensus is divided with 12 Buy and 16 Hold ratings, targeting $52.67 average price. Recent news highlights institutional buying and grid investments to support rising data center demand.
Investment outlook balances growth from infrastructure spending and data center demand against execution risks and debt levels. The stock offers value below analyst targets with dividend income, but faces headwinds from capital expenditure requirements and interest rate sensitivity. Current valuation at P/E 25.05 appears reasonable for sector growth prospects.
TransMedics Group (TMDX) trades at $86.43, down 2.24% amid recent earnings misses but maintains strong analyst support with a $99.57 consensus target. The stock shows bullish technical signals with support at $84-87, though RSI levels suggest overbought conditions. Fundamentally, the company demonstrates robust profitability with 58.69% gross margins and 22.69% net income margins, despite recent quarterly earnings falling short of expectations.
Investment outlook remains positive given strong institutional backing and growth potential in organ transplant technology, though risks include ongoing fiduciary investigations and margin pressure from increased operating costs. The stock offers 15% upside to consensus targets but requires monitoring of Q3 earnings performance and legal developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
